Comparison in metabolic control and treatment satisfaction with continuous subcutaneous insulin infusion and multiple daily injections in children at onset of type 1 diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN64351161

Enrollment

Registered

2007-07-03

Start date

2001-12-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus Nutritional, Metabolic, Endocrine Type 1 diabetes mellitus

Interventions

Group 1: Continuous subcutaneous insulin infusion for 24 months Group 2: Multiple daily insulin injections for 24 months

Eligibility

Inclusion criteria

Inclusion criteria: Children and adolescents (age 7 to 17 years) with newly diagnosed (within 3 weeks) type 1 diabetes mellitus.

Exclusion criteria

Exclusion criteria: Other relavent diseases.

Design outcomes

Primary

Measure	Time frame
The following were measured at baseline, 1 month, 6, 12 and 24 months: 1. Metabolic control (HbA1c) 2. Treatment satisfaction (Qestionnaires Diabetes Treatment Satisfaction Questionnaire [DTSQ]) 3. Safety (Registration of hospitalization for ketoacidosis [defined as pH <7.3] and major hypoglycemic episodes and/or technical problems)	—

Secondary

Measure	Time frame
The following were measured at baseline, 1 month, 6, 12 and 24 months: 1. BMI 2. Isulin requirment 3. Adverse events 4. C-petide 5. insulin-like growth factor-1 (IGF-1) 6. Binding proteins	—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026